HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J H Beijnen Selected Research

Carboplatin (JM8)

9/2006Sensitive inductively coupled plasma mass spectrometry assay for the determination of platinum originating from cisplatin, carboplatin, and oxaliplatin in human plasma ultrafiltrate.
3/2005A phase I study of intraperitoneal topotecan in combination with intravenous carboplatin and paclitaxel in advanced ovarian cancer.
11/2002Relationship between irreversible alopecia and exposure to cyclophosphamide, thiotepa and carboplatin (CTC) in high-dose chemotherapy.
6/2002Kinetic modeling and efficacy of intraperitoneal paclitaxel combined with intravenous cyclophosphamide and carboplatin as first-line treatment in ovarian cancer.
3/2002Relationship between exposure and toxicity in high-dose chemotherapy with cyclophosphamide, thiotepa and carboplatin.
7/2001Population pharmacokinetics of ifosfamide and its 2- and 3-dechloroethylated and 4-hydroxylated metabolites in resistant small-cell lung cancer patients.
7/2001Phase II study of a multi-course high-dose chemotherapy regimen incorporating cyclophosphamide, thiotepa, and carboplatin in stage IV breast cancer.
6/2001Dose-finding and pharmacological study of ifosfamide in combination with paclitaxel and carboplatin in resistant small-cell lung cancer.
10/2000Cremophor EL pharmacokinetics in a phase I study of paclitaxel (Taxol) and carboplatin in non-small cell lung cancer patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J H Beijnen Research Topics

Disease

94Neoplasms (Cancer)
09/2022 - 01/2000
22Breast Neoplasms (Breast Cancer)
02/2021 - 01/2000
10Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 10/2000
9Neutropenia
07/2015 - 04/2000
8Melanoma (Melanoma, Malignant)
01/2023 - 10/2008
7Ovarian Neoplasms (Ovarian Cancer)
08/2006 - 01/2000
6Sarcoma (Soft Tissue Sarcoma)
07/2020 - 06/2000
6Prostatic Neoplasms (Prostate Cancer)
01/2020 - 09/2002
6Colorectal Neoplasms (Colorectal Cancer)
01/2019 - 05/2000
5Neoplasm Metastasis (Metastasis)
03/2016 - 05/2001
4Disease Progression
01/2022 - 04/2002
4Lymphoma (Lymphomas)
07/2018 - 06/2001
4Non-Hodgkin Lymphoma (Lymphosarcoma)
12/2012 - 02/2007
4Infections
04/2012 - 12/2001
4Vomiting
06/2007 - 06/2000
4Nausea
06/2007 - 06/2000
3Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2022 - 06/2001
3Renal Cell Carcinoma (Grawitz Tumor)
07/2020 - 07/2010
3Stomach Neoplasms (Stomach Cancer)
12/2017 - 02/2003
3Leishmaniasis
02/2017 - 12/2006
3Carcinoma (Carcinomatosis)
10/2014 - 06/2002
3Rheumatoid Arthritis
01/2011 - 09/2000
3Thrombocytopenia (Thrombopenia)
11/2005 - 12/2000
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2020 - 06/2000
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2017 - 08/2016
2Glioma (Gliomas)
03/2016 - 07/2001
2Hyperbilirubinemia
01/2014 - 07/2006
2Colonic Neoplasms (Colon Cancer)
09/2013 - 09/2010
2Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
12/2012 - 01/2010

Drug/Important Bio-Agent (IBA)

26Paclitaxel (Taxol)FDA LinkGeneric
10/2014 - 01/2000
12Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2000
12Antineoplastic Agents (Antineoplastics)IBA
07/2015 - 03/2001
9Cisplatin (Platino)FDA LinkGeneric
04/2015 - 11/2000
9Carboplatin (JM8)FDA LinkGeneric
09/2006 - 10/2000
8PlatinumIBA
01/2022 - 06/2002
7Docetaxel (Taxotere)FDA Link
10/2014 - 04/2000
6TamoxifenFDA LinkGeneric
11/2018 - 08/2009
6GemcitabineFDA Link
12/2015 - 11/2005
6TrabectedinIBA
04/2010 - 12/2000
6Topotecan (Hycamtin)FDA LinkGeneric
03/2009 - 01/2000
6Cyclosporine (Ciclosporin)FDA LinkGeneric
10/2007 - 07/2000
5Adenosine Triphosphate (ATP)IBA
01/2019 - 01/2000
5Capecitabine (Xeloda)FDA Link
12/2017 - 01/2014
5Doxorubicin (Adriamycin)FDA LinkGeneric
10/2014 - 10/2000
5Rituximab (Mabthera)FDA Link
12/2012 - 01/2010
5Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2005 - 06/2001
4niraparibIBA
01/2018 - 01/2017
4Fluorouracil (Carac)FDA LinkGeneric
12/2017 - 05/2001
4miltefosine (Impavido)IBA
02/2017 - 12/2006
4eribulinFDA Link
07/2015 - 12/2012
4Oxaliplatin (Eloxatin)FDA LinkGeneric
04/2015 - 08/2005
4Member 1 Subfamily B ATP Binding Cassette TransporterIBA
10/2013 - 06/2000
4Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric
11/2002 - 01/2001
4kahalalide FIBA
09/2002 - 07/2001
4cremophor ELIBA
11/2001 - 07/2000
4IfosfamideFDA LinkGeneric
09/2001 - 06/2000
3dabrafenibIBA
01/2023 - 06/2016
3trametinibIBA
01/2023 - 06/2016
3Poly(ADP-ribose) Polymerase InhibitorsIBA
02/2021 - 01/2017
3Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
02/2021 - 01/2017
3Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2021 - 03/2012
34-hydroxy-N-desmethyltamoxifenIBA
11/2018 - 04/2013
3plitidepsin (aplidine)IBA
01/2018 - 05/2000
3Epirubicin (Ellence)FDA LinkGeneric
04/2015 - 08/2001
3taxaneIBA
04/2014 - 08/2006
3Taxoids (Taxanes)IBA
04/2014 - 05/2001
3L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
07/2010 - 09/2001
3Capsules (Microcapsules)IBA
04/2010 - 01/2002
3BilirubinIBA
11/2007 - 09/2003
3SolutionsIBA
10/2007 - 07/2000
3Methotrexate (Mexate)FDA LinkGeneric
02/2007 - 06/2001
3PolymersIBA
01/2007 - 11/2001
3tipifarnib (R115777)IBA
11/2005 - 01/2002
3Triethylenephosphoramide (TEPA)IBA
11/2002 - 01/2001
3AndrogensIBA
09/2002 - 01/2001
3ElacridarIBA
07/2002 - 01/2001
2olaparibIBA
02/2021 - 12/2013
2pazopanibFDA Link
07/2020 - 12/2017
2Abiraterone AcetateIBA
01/2020 - 01/2017
2ATP-Binding Cassette Transporters (ABC Transporters)IBA
01/2019 - 01/2005
2Estrogen ReceptorsIBA
11/2018 - 04/2013
2enzalutamideIBA
04/2018 - 01/2017
2vosaroxinIBA
01/2017 - 08/2016
2VemurafenibIBA
01/2017 - 01/2014
2QuinolonesIBA
01/2017 - 08/2016
2Cytarabine (Cytosar-U)FDA LinkGeneric
08/2016 - 06/2001
2Prostate-Specific Antigen (Semenogelase)IBA
07/2015 - 07/2015
2ElectrolytesIBA
02/2015 - 11/2005
2oseltamivir carboxylateIBA
05/2013 - 04/2012
2Messenger RNA (mRNA)IBA
11/2011 - 06/2011
2Biomarkers (Surrogate Marker)IBA
06/2011 - 01/2006
2CD20 AntigensIBA
01/2011 - 01/2011
2indibulinIBA
04/2010 - 06/2007

Therapy/Procedure

21Drug Therapy (Chemotherapy)
01/2022 - 01/2000
11Therapeutics
06/2016 - 01/2000
4Castration
01/2020 - 07/2015
4Oral Administration
10/2007 - 05/2001
3Cytoreduction Surgical Procedures
02/2015 - 11/2000
3Transplantation
03/2002 - 04/2000
2Hyperthermic Intraperitoneal Chemotherapy
02/2015 - 05/2001